SCHEMBL231091

SCHEMBL231091

NC(Cc1ccccn1)(Cc1ccccn1)C(N)(Cc1ccccn1)Cc1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.56
HRH1 P35367 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 1/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
MAPT P10636 1/20 0.47
LIN28A Q9H9Z2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIN3A Q8TCU5 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PRMT1 Q99873 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28620601 0.96 FDPS (0.53) FDPSHRH1SMN1; SMN2L3MBTL1POLB
SCHEMBL31312939 0.86 HRH1 (0.54) FDPSHRH1SMN1; SMN2L3MBTL1MAOA
SCHEMBL1971651 0.86 HRH1 (0.46) FDPSHRH1SMN1; SMN2L3MBTL1POLB
SCHEMBL5556933 0.84 HRH1 (0.47) FDPSHRH1SMN1; SMN2L3MBTL1MAOA
SCHEMBL28265938 0.83 HRH1 (0.50) FDPSHRH1SMN1; SMN2L3MBTL1POLB
SCHEMBL7003387 0.83 HRH1 (0.50) FDPSHRH1SMN1; SMN2L3MBTL1MAOA
SCHEMBL3902944 0.83 HRH1 (0.50) FDPSHRH1SMN1; SMN2L3MBTL1MAOA
SCHEMBL7123795 0.82 HRH1 (0.55) FDPSHRH1SMN1; SMN2L3MBTL1MAOA
SCHEMBL1462070 0.81 HRH1 (0.53) FDPSHRH1SMN1; SMN2L3MBTL1MAOA
SCHEMBL4262034 0.81 HRH1 (0.48) FDPSHRH1SMN1; SMN2L3MBTL1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024150130-A2 NECROSIS INHIBITOR LINKGEVITY LIMITED (GB) 2024-07-18 WO claimed
EP-4346399-A1 METHODS FOR STORING MRNA COMPOSITIONS eTheRNA immunotherapies NV (BE) 2024-04-10 EP claimed
CN-115745457-A High-adaptability concrete superplasticizer, preparation method and application thereof 南京博特新材料有限公司 2023-03-07 CN claimed
CN-115725035-A Slump-retaining concrete superplasticizer, preparation method and application thereof 博特新材料泰州有限公司 2023-03-03 CN claimed
CN-115028784-A Preparation method of bio-based elastomer and preparation method of bio-based elastomer modified asphalt mixture 东南大学 2022-09-09 CN claimed
CN-110862544-B Preparation method of composite adsorption type solid water reducing agent for sulphoaluminate cement 北京工业大学 2021-09-14 CN claimed
CN-109942220-B Preparation method of salt-resistant amphoteric polycarboxylic acid high-performance water reducing agent 北京工业大学 2021-07-23 CN claimed
CN-109942754-B Method for preparing delayed coagulation type superplasticizer by atom transfer radical polymerization 北京工业大学 2021-06-25 CN claimed
EP-3837541-A1 CHELATOR-COATED FIELD EFFECT TRANSISTOR AND DEVICES AND METHODS USING SAME Autonomous Medical Devices Incorporated (US) 2021-06-23 EP claimed
CN-109956696-B Synthesis method of side chain adsorption type concrete superplasticizer 北京工业大学 2021-06-04 CN claimed
EP-1497276-A1 CONVERSION OF TAXANE MOLECULES Natural Pharmaceuticals, Inc. (US) 2005-01-19 EP claimed
WO-2004084799-A2 PHARMACEUTICAL COMPOSITIONS FOR INHIBITING METAL ION DEPENDENT ENZYMATIC ACTIVITY AND METHODS FOR THE USE THEREOF APPELBAUM JERACHMIEL (IL) 2004-10-07 WO claimed
WO-2003087079-A1 CONVERSION OF TAXANE MOLECULES NATURAL PHARMACEUTICALS, INC. (US) 2003-10-23 WO claimed
EP-0740528-B1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX THERAPEUTICS INC (US) 2003-03-26 EP claimed
EP-0740528-A4 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP (US) 1998-04-01 EP claimed
US-5733572-A Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles IMARX PHARMACEUTICAL CORP. (US) 1998-03-31 US claimed
WO-1997033473-A1 METHOD FOR REDUCING BCL-2 EXPRESSING CELLS RESISTANCE TO DEATH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-09-18 WO claimed
EP-0740528-A1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP. (US) 1996-11-06 EP claimed
WO-1995015118-A1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP. (US) 1995-06-08 WO claimed
US-5082851-A Pharmaceutical composition for protecting the heart comprising a heterocyclic ethylenediamine derivative and methods for the use thereof HADASSAH MEDICAL ORGANIZATION (IL) 1992-01-21 US claimed